Skip to main content
. Author manuscript; available in PMC: 2016 Jun 24.
Published in final edited form as: J Clin Oncol. 2005 Aug 20;23(24):5605–5612. doi: 10.1200/JCO.2005.08.147

Table 1.

Patient Characteristics

Characteristic Regimen

Interval Secondary Cytoreduction (n = 216) No Interval Secondary Cytoreduction (n = 208)


No. of Patients % No. of Patients %
Age
 <40 years 11 5.1 14 6.7
 40–49 years 42 19.4 38 18.3
 50–59 years 68 31.5 71 34.0
 60–69 years 60 27.8 59 28.2
 ≥70 years 35 16.2 26 12.4

Race
 Black 10 4.6 14 6.7
 White 198 91.7 183 88.0
 Hispanic 5 2.3 6 2.9
 Other 3 1.4 5 2.4

Performance status
 0 83 38.4 83 39.7
 1 119 55.1 108 51.9
 2 14 6.5 17 8.1

Cell type
 Serous adenocarcinoma 165 76.4 159 76.4
 Endometrioid adenocarcinoma 17 7.9 11 5.3
 Mixed epithelial 20 9.3 17 8.2
 Other 14 6.5 21 10.1

Measurable disease 152 70.4 145 69.7

Stage
 III 200 92.6 200 96.2
 IV 16 7.4 8 3.8